{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:07:42Z","timestamp":1794377262389,"version":"4.9.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.ymgme.2010.07.011","type":"journal-article","created":{"date-parts":[[2010,7,24]],"date-time":"2010-07-24T07:05:16Z","timestamp":1279955116000},"page":"332-337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Use of cardiac magnetic resonance imaging to evaluate cardiac structure, function and fibrosis in children with infantile Pompe disease on enzyme replacement therapy"],"prefix":"10.1016","volume":"101","author":[{"given":"Piers C.A.","family":"Barker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara K.","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Darty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Ing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"DeArmey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya S.","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2010.07.011_bb0005","series-title":"The Metabolic and Molecular Basis of Inherited Disease","first-page":"3389","article-title":"Glycogen storage disease type II: acid alpha-glucosidase (acid maltase deficiency)","author":"Hirschhorn","year":"2001"},{"issue":"5 Suppl","key":"10.1016\/j.ymgme.2010.07.011_bb0010","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.jpeds.2004.01.053","article-title":"Pompe disease in infants and children","volume":"144","author":"Kishnani","year":"2004","journal-title":"J. Pediatr."},{"issue":"5","key":"10.1016\/j.ymgme.2010.07.011_bb0015","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","article-title":"A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease","volume":"148","author":"Kishnani","year":"2006","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2010.07.011_bb0020","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1542\/peds.112.2.332","article-title":"The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature","volume":"112","author":"van den Hout","year":"2003","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.ymgme.2010.07.011_bb0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ymgme.2010.07.011_bb0030","first-page":"132","article-title":"Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial","volume":"3","author":"Amalfitano","year":"2001","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2010.07.011_bb0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpeds.2006.02.035","article-title":"Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease","volume":"149","author":"Kishnani","year":"2006","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2010.07.011_bb0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nmd.2004.10.009","article-title":"Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial","volume":"15","author":"Klinge","year":"2005","journal-title":"Neuromuscul. Disord."},{"issue":"15","key":"10.1016\/j.ymgme.2010.07.011_bb0045","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe's disease","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ymgme.2010.07.011_bb0050","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00246-008-9267-3","article-title":"Cardiac remodeling after enzyme replacement therapy with acid alpha-glucosidase for infants with Pompe Disease","volume":"29","author":"Levine","year":"2008","journal-title":"Pediatr. Cardiol."},{"issue":"5","key":"10.1016\/j.ymgme.2010.07.011_bb0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.gim.0000195896.04069.5f","article-title":"Electrocardiographic response to enzyme replacement therapy for Pompe disease","volume":"8","author":"Ansong","year":"2006","journal-title":"Genet. Med."},{"issue":"10","key":"10.1016\/j.ymgme.2010.07.011_bb0060","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/GIM.0b013e318183722f","article-title":"Arrhythmias in patients receiving enzyme replacement therapy for infantile Pompe disease","volume":"10","author":"McDowell","year":"2008","journal-title":"Genet. Med."},{"issue":"12","key":"10.1016\/j.ymgme.2010.07.011_bb0065","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1161\/CIRCULATIONAHA.107.723387","article-title":"Images in cardiovascular medicine. Cryptogenic ventricular arrhythmias and sudden death by Fabry disease: prominent infiltration of cardiac conduction tissue","volume":"116","author":"Frustaci","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ymgme.2010.07.011_bb0070","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/ejechocard\/jen132","article-title":"Fabry's disease presenting as ventricular tachycardia and left ventricular \u2018hypertrophy\u2019","volume":"9","author":"Joshi","year":"2008","journal-title":"Eur. J. Echocardiogr."},{"issue":"6","key":"10.1016\/j.ymgme.2010.07.011_bb0075","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.amjcard.2005.05.033","article-title":"Prevalence and clinical significance of cardiac arrhythmia in Anderson\u2013Fabry disease","volume":"96","author":"Shah","year":"2005","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ymgme.2010.07.011_bb0080","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2214\/AJR.05.0442","article-title":"MRI characterization of myocardial tissue in patients with Fabry's disease","volume":"188","author":"Imbriaco","year":"2007","journal-title":"AJR Am. J. Roentgenol."},{"issue":"23","key":"10.1016\/j.ymgme.2010.07.011_bb0085","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.ehj.2003.09.017","article-title":"Gadolinium enhanced cardiovascular magnetic resonance in Anderson\u2013Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium","volume":"24","author":"Moon","year":"2003","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ymgme.2010.07.011_bb0090","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/10976640600605002","article-title":"The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson\u2013Fabry disease","volume":"8","author":"Moon","year":"2006","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"6","key":"10.1016\/j.ymgme.2010.07.011_bb0095","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1460-9592.2004.01242.x","article-title":"Anaesthetic management of infants with glycogen storage disease type II: a physiological approach","volume":"14","author":"Ing","year":"2004","journal-title":"Paediatr. Anaesth."},{"issue":"8","key":"10.1016\/j.ymgme.2010.07.011_bb0100","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1460-9592.2007.02215.x","article-title":"Cardiac arrhythmias following anesthesia induction in infantile-onset Pompe disease: a case series","volume":"17","author":"Wang","year":"2007","journal-title":"Paediatr. Anaesth."},{"issue":"3","key":"10.1016\/j.ymgme.2010.07.011_bb0105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1081\/JCMR-120022260","article-title":"Rapid evaluation of right and left ventricular function and mass using real-time true-FISP cine MR imaging without breath-hold: comparison with segmented true-FISP cine MR imaging with breath-hold","volume":"5","author":"Hori","year":"2003","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.ymgme.2010.07.011_bb0110","series-title":"Cardiovascular Magnetic Resonance","author":"Bellenger","year":"2002"},{"key":"10.1016\/j.ymgme.2010.07.011_bb0115","series-title":"Echocardiography in Pediatric Heart Disease","author":"Snider","year":"1997"},{"key":"10.1016\/j.ymgme.2010.07.011_bb0120","first-page":"1","article-title":"Developments in the Treatment of Pompe Disease","author":"Li","year":"2006","journal-title":"U.S. Cardiovas. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2010.07.011_bb0125","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1148\/radiology.169.2.2971985","article-title":"Estimation of human myocardial mass with MR imaging","volume":"169","author":"Katz","year":"1988","journal-title":"Radiology"},{"issue":"855","key":"10.1016\/j.ymgme.2010.07.011_bb0130","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1259\/bjr.72.855.10396215","article-title":"A comparison of MRI and echocardiography in hypertrophic cardiomyopathy","volume":"72","author":"Devlin","year":"1999","journal-title":"Br. J. Radiol."},{"issue":"6","key":"10.1016\/j.ymgme.2010.07.011_bb0135","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1046\/j.1523-1755.1999.00786.x","article-title":"Echocardiography overestimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging","volume":"56","author":"Stewart","year":"1999","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.ymgme.2010.07.011_bb0140","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1081\/JCMR-120022267","article-title":"How we perform delayed enhancement imaging","volume":"5","author":"Kim","year":"2003","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"1","key":"10.1016\/j.ymgme.2010.07.011_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2009.06.059","article-title":"Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications","volume":"55","author":"Kim","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.ymgme.2010.07.011_bb0150","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.jacc.2005.10.074","article-title":"Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging","volume":"47","author":"Klem","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ymgme.2010.07.011_bb0155","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.hfc.2009.02.009","article-title":"Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance","volume":"5","author":"Senthilkumar","year":"2009","journal-title":"Heart Fail. Clin."},{"issue":"12","key":"10.1016\/j.ymgme.2010.07.011_bb0160","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1136\/hrt.2005.067355","article-title":"Cardiac magnetic resonance in myocardial disease","volume":"93","author":"Sechtem","year":"2007","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.ymgme.2010.07.011_bb0165","doi-asserted-by":"crossref","first-page":"W97","DOI":"10.2214\/AJR.08.1201","article-title":"Delayed-enhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy","volume":"192","author":"De Cobelli","year":"2009","journal-title":"Am. J. Roentgenol."},{"issue":"10","key":"10.1016\/j.ymgme.2010.07.011_bb0170","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.amjcard.2005.11.087","article-title":"Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy","volume":"97","author":"Beer","year":"2006","journal-title":"Am. J. Cardiol."},{"issue":"12","key":"10.1016\/j.ymgme.2010.07.011_bb0175","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.2459\/01.JCM.0000296538.82763.f0","article-title":"Myocardial late gadolinium enhancement in specific cardiomyopathies by cardiovascular magnetic resonance: a preliminary experience","volume":"8","author":"Silva","year":"2007","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"issue":"16","key":"10.1016\/j.ymgme.2010.07.011_bb0180","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/eurheartj\/ehp152","article-title":"Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy","volume":"30","author":"Leonardi","year":"2009","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ymgme.2010.07.011_bb0185","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/hrt.2006.104026","article-title":"Effects of enzyme replacement therapy on the cardiomyopathy of Anderson\u2013Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa","volume":"94","author":"Hughes","year":"2008","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.ymgme.2010.07.011_bb0190","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s10545-008-0848-3","article-title":"Twenty-four-month alpha-galactosidase A replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parameters","volume":"31","author":"Koskenvuo","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2010.07.011_bb0195","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/522236","article-title":"Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance","volume":"81","author":"Sun","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2010.07.011_bb0200","unstructured":"Myozyme, package insert. Available from: http:\/\/www.myozyme.com\/PDF\/mz_pi.pdf."},{"issue":"1","key":"10.1016\/j.ymgme.2010.07.011_bb0205","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ymgme.2009.08.003","article-title":"Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants","volume":"99","author":"Kishnani","year":"2010","journal-title":"Mol. Genet. Metab."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719210002738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719210002738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:19:47Z","timestamp":1761088787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719210002738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1096719210002738"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2010.07.011","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of cardiac magnetic resonance imaging to evaluate cardiac structure, function and fibrosis in children with infantile Pompe disease on enzyme replacement therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2010.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}